Management of punding in Parkinson’s disease: an open-label prospective study

被引:0
|
作者
A. Fasano
L. Ricciardi
M. Pettorruso
A. R. Bentivoglio
机构
[1] Università Cattolica del Sacro Cuore Largo Agostino Gemelli,Istituto di Neurologia
[2] 8,Department of Neurosciences, Psychiatry and Anaesthesiological Science
[3] Neuromed Institute,Department of Psychiatry
[4] University of Messina,undefined
[5] Catholic University of Sacred Heart,undefined
来源
Journal of Neurology | 2011年 / 258卷
关键词
Amantadine; Parkinson’s disease; Punding; Therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Punding, a peculiar stereotyped behavior characterized by intense fascination with complex, excessive, non-goal-oriented, repetitive activities, is a quite rare condition complicating Parkinson’s disease (PD). It is triggered by dopaminergic therapy and could have a strong impact on patient quality of life. No study has specifically investigated medical management of this condition, and only a few anecdotal reports have provided therapeutic hints. Given the suggested similarities to drug-induced dyskinesias, we have previously suggested a multistep algorithm for management of punding. We conducted a prospective open-label study on ten PD punders aimed at testing its validity. In two cases, reduction of levodopa therapy was efficacious; amantadine was effective in controlling punding in four cases; in the remaining cases, quetiapine was employed, with mild efficacy in two cases.
引用
收藏
页码:656 / 660
页数:4
相关论文
共 50 条
  • [21] Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: A pilot open-label study
    Marsh, L.
    Bassett, S. S.
    Biglan, K.
    Gerstenhaber, M.
    Williams, J. R.
    MOVEMENT DISORDERS, 2007, 22 (12) : I - II
  • [22] Open-Label Conversion Study of Pramipexole to Ropinirole Prolonged Release in Parkinson's Disease
    Lyons, Kelly E.
    Pahwa, Rajesh
    MOVEMENT DISORDERS, 2009, 24 (14) : 2121 - 2127
  • [23] Effects of rasagiline on freezing of gait in Parkinson's disease - an open-label, multicenter study
    Cibulcik, Frantisek
    Benetin, Jan
    Kurca, Egon
    Grofik, Milan
    Dvorak, Miloslav
    Richter, Denis
    Donath, Vladimir
    Kothaj, Jan
    Minar, Michal
    Valkovic, Peter
    BIOMEDICAL PAPERS-OLOMOUC, 2016, 160 (04): : 549 - 552
  • [24] An open-label pilot study with high-dose thiamine in Parkinson's disease
    Costantini, Antonio
    Fancellu, Roberto
    NEURAL REGENERATION RESEARCH, 2016, 11 (03) : 406 - 407
  • [25] Punding in Parkinson's disease
    Ruiz, PJG
    Gancedo, EM
    NEUROLOGIA, 2002, 17 (04): : 228 - 228
  • [26] Punding in Parkinson's disease
    Tokcaer, A. Bora
    Kapucu, O.
    Ince, N. Erdogmus
    Akdemir, U. O.
    MOVEMENT DISORDERS, 2007, 22 : S246 - S247
  • [27] Evaluation of open-label rotigotine treatment in advanced Parkinson's disease
    Lyons, Kelly E.
    Pahwa, Rajesh
    Boroojerdi, Babek
    NEUROLOGY, 2008, 70 (11) : A59 - A59
  • [28] Evaluation of open-label rotigotine treatment in advanced Parkinson's disease
    Lyons, K. E.
    Pahwa, R.
    Boroojerdi, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 118 - 118
  • [29] Evaluation of open-label rotigotine treatment in advanced Parkinson's disease
    Lyons, K. E.
    Pahwa, R.
    Boroojerdi, B.
    MOVEMENT DISORDERS, 2008, 23 (01) : S215 - S215
  • [30] Open label study of cannabidiol in Parkinson's disease
    Leehey, M.
    Liu, Y.
    Epstein, C.
    Hart, F.
    Bainbridge, J.
    Cook, M.
    Sillau, S.
    Baud, Z.
    Newman, H.
    MOVEMENT DISORDERS, 2017, 32